EGF and cancer: Upon receptor binding, EGF and TGF activate downstream mitogen-activated protein kinase (MAPK) and AKT-mammalian target of rapamycin (mTOR) pathways (15), which regulate apoptosis and cell proliferation (16), while inducible nitric oxide synthase (iNOS) modulates cellular bioenergetics pathways in cancer (17).